发明名称 |
THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES |
摘要 |
The present disclosure is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The disclosure also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present disclosure also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists. |
申请公布号 |
EP1624892(B1) |
申请公布日期 |
2011.04.20 |
申请号 |
EP20040760993 |
申请日期 |
2004.05.10 |
申请人 |
ABBOTT BIOTHERAPEUTICS CORP. |
发明人 |
WILLIAMS, MARNA;TSO, YUN, J.;LANDOLFI, NICOLAS, F.;POWERS, DAVID B.;LIU, GAO |
分类号 |
A61K39/395;A61K;A61K47/48;A61P35/00;A61P37/00;C07K14/705;C07K16/28;C12N5/20 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|